Japan Contraceptive Devices Market Report 2022 to 2030

Japan Contraceptive Devices Market Analysis

$ 3999

Japan's Contraceptive Devices Market is expected to witness growth from $802 Mn in 2022 to $1540 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. In Japan, people are becoming more and more aware of the advantages of adopting contraceptive methods. As a result, there is now more demand for contraceptive methods. The market is segmented by type and by gender. Some key players in this market include FUJI LATEX, Okamoto Industries, Sato Pharmaceutical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

ID: IN10JPMD005 CATEGORY: Medical Devices GEOGRAPHY: Japan AUTHOR: Jigyasu Bhandari

Buy Now

Japan Contraceptive Devices Healthcare Market Executive Analysis

Japan's contraceptive Devices Market is expected to witness growth from $802 Mn in 2022 to $1540 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. Japan's per-person healthcare expenditure has increased significantly, from $4360 in 2019, which was 10.74% of GDP, to $4478 in 2022, which would be 11.44% of GDP. The nation has a sophisticated and intricate healthcare infrastructure as a result of its high healthcare spending. Japan had a mortality rate of 12.7 per 1,000 inhabitants in 2022.

In Japan, there were 5 maternal deaths per 100,000 live births as of 2019. Chlamydia, gonorrhoea, and syphilis are the three STDs with the highest frequency in Japan; in 2021, there were 13,769 cases reported of chlamydia, 6,285 cases of gonorrhoea, and 2,975 cases of syphilis. Birth control techniques, often known as contraceptive devices, are frequently used in Japan for family planning. In order to provide people more control over their reproductive health and family planning, contraceptive methods like condoms, birth control tablets, intrauterine devices, and implants can help avoid unexpected births. Contraceptive methods can lower the rate of maternal mortality by reducing unplanned births. This benefit might not be as noticeable in Japan because of the country's already low maternal death rates, but it is still significant. Some contraceptive methods, like condoms, have a dual purpose by preventing the spread of STIs as well as other sexually transmitted infections.

Japan Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In Japan, people are becoming more and more aware of the advantages of adopting contraceptive methods. As a result, there is now more demand for contraceptive methods. The Japanese government has long advocated for population control and family planning programmes. Additionally, it has implemented rules and initiatives to support the use of contraceptive methods. This has made the market for contraceptive devices more hospitable to expansion. Manufacturers are always coming out with new, better contraceptives that are more efficient, secure, and practical to use. This has also helped the market for contraceptive devices to expand.

Market Restraints

Being a conservative nation, Japan may prohibit the use of contraceptive methods for several cultural reasons. For instance, there can be pressure to have children or a stigma associated with utilising contraceptives. Some contraceptive methods can be very expensive, which may prevent some people from using them. Some contraceptive methods can cause negative effects, which may make some people reluctant to use them.

Competitive Landscape

Key Players

FUJI LATEX (JP)
Okamoto Industries (JP)
Sato Pharmaceutical (JP)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Recent Notable Deals

2021: In 2021, Fuji Latex cooperates with the Japanese government to create a new condom that is simpler to use. The project, which aims to encourage condom use in Japan, was funded by the government.

2020: In 2020, Thai Nippon Rubber Industry's condom division is set to be acquired by Okamoto Industries, Inc. Okamoto Industries was able to enter the Thai market as a result of this transaction, which also increased its global reach.

Healthcare Policies and Regulatory Landscape

The Pharmaceuticals and Medical Devices Act (PMD Act), which was passed in 2014 to safeguard the safety and efficacy of contraceptive devices, governs the healthcare policies and regulatory environment in Japan's contraceptive devices sector. The PMD Act creates a legal framework for the certification, production, importation, and distribution of contraceptive devices and calls for producers and importers to adhere to stringent safety and quality requirements. In Japan, the Ministry of Health, Labour, and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA) both conduct thorough reviews of medical devices as part of the regulatory process. Applications for regulatory approval from manufacturers must be comprehensive and include information on safety and efficacy, as well as data from clinical trials. It may take several years to finish the review process because it is time-consuming and complicated.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.